Skip to main content

Doxorubicin-Loaded Albumin Nanoparticles: Formulation and Characterization

Buy Article:

$113.00 plus tax (Refund Policy)

Abstract:

The purpose of the present study was to develop Doxorubicin (Dox) loaded albumin nanoparticles for regional drug release in solid tumours. Bovine serum albumin nanoparticles were prepared by coacervation method. The nanoparticles were characterized using various techniques: Scanning Electron Microscopy (SEM), Differential Scanning Calorimetry (DSC), Dynamic Light Scattering (DLS) technique and Laser Doppler Electrophoresis (LDE) method. The entrapment of Dox in albumin nanoparticles also found out and in vitro release of drug was studied. The results show that the size of albumin nanoparticles increases from Z average of 67 nm to 98 and 106 nm for two different methods; A and B of drug loading, respectively. The SEM results confirm the spherical shape of nanoparticles which made at 4 °C. The results show that the size of nanoparticles decreases by decreasing temperature in their production process.

Keywords: DOXORUBICIN HYDROCHLORIDE; DRUG DELIVERY; DRUG RELEASE; DSC; NANOMEDICINE; SEM

Document Type: Research Article

DOI: https://doi.org/10.1166/jnn.2010.2832

Publication date: 2010-11-01

More about this publication?
  • Journal for Nanoscience and Nanotechnology (JNN) is an international and multidisciplinary peer-reviewed journal with a wide-ranging coverage, consolidating research activities in all areas of nanoscience and nanotechnology into a single and unique reference source. JNN is the first cross-disciplinary journal to publish original full research articles, rapid communications of important new scientific and technological findings, timely state-of-the-art reviews with author's photo and short biography, and current research news encompassing the fundamental and applied research in all disciplines of science, engineering and medicine.
  • Editorial Board
  • Information for Authors
  • Subscribe to this Title
  • Terms & Conditions
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free ContentFree content
  • Partial Free ContentPartial Free content
  • New ContentNew content
  • Open Access ContentOpen access content
  • Partial Open Access ContentPartial Open access content
  • Subscribed ContentSubscribed content
  • Partial Subscribed ContentPartial Subscribed content
  • Free Trial ContentFree trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more